1. Prevention of allograft HCV recurrence with peri‐transplant human monoclonal antibody MBL‐HCV1 combined with a single oral direct‐acting antiviral: A proof‐of‐concept study. Issue 3 (7th November 2016) Authors: Smith, H. L.; Chung, R. T.; Mantry, P.; Chapman, W.; Curry, M. P.; Schiano, T. D.; Boucher, E.; Cheslock, P.; Wang, Y.; Molrine, D. C. Journal: Journal of viral hepatitis Issue: Volume 24:Issue 3(2017) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗